Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 27 Feb 2007):

In-vivo quantification of dose-dependent dopamine transporter blockade in the rat striatum with small animal SPECT.

Full Abstract

OBJECTIVE:
This study investigated dopamine transporter blockade in the rat striatum after treatment with various doses of methylphenidate using a high-resolution small animal SPECT ('TierSPECT') and I-FP-CIT.

METHODS:
I-FP-CIT was administered intravenously 1 h after intraperitoneal injection of methylphenidate (3 mg.kg, 10 mg.kg) or vehicle. Rats underwent scanning 2 h after radioligand application. From the spatial resolution of the imaging system and the size of the rat striatum followed that 'true' radioactivity concentrations were underestimated by approximately 50%. From cerebellar and partial volume corrected striatal radioactivity concentrations, striatal equilibrium ratios (V3'') were computed as estimations of the binding potential.

RESULTS:
Vehicle-treated animals yielded striatal V3'' values of 3.5+/-0.9 (mean+/-SD). After pre-treatment with 3 mg.kg and 10 mg.kg methylphenidate, striatal V3'' values were reduced to 2.4+/-0.8 (independent t-test, two-tailed, P=0.026) and 1.7+/-0.6 (P<0.001), respectively.

CONCLUSIONS:
This first in-vivo study of rat dopamine transporter binding after pre-treatment with various doses of methylphenidate showed a dose-dependent reduction of striatal dopamine transporter binding. Results indicate that in-vivo quantification of dopamine transporter binding is feasible with I-FP-CIT and the TierSPECT method. This may be of future relevance for investigating in-vivo binding properties as well as pharmacological profiles of novel agents acting at the dopamine transporter binding site. Moreover, alterations of striatal transporter densities may be investigated in animal models of neurological and psychiatric diseases such as attention-deficit/hyperactivity disorder and Parkinson's disease.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Nikolaus, Susanne (S); Antke, Christina (C); Beu, Markus (M); Kley, Konstantin (K); Larisch, Rolf (R); Wirrwar, Andreas (A); Müller, Hans-Wilhelm (HW);

Affiliation: Clinic of Nuclear Medicine, University Hospital Düsseldorf, Germany. Susanne.Nikolaus(-atsign-)uni-duesseldorf.de

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Nuclear medicine communications (Nucl Med Commun), published in England. (Language: eng)

Reference: 2007-Mar; vol 28 (issue 3) : pp 207-13

Dates: Created 2007/01/31; Completed 2007/04/02;

PMID: 17264780, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Dopamine Plasma Membrane Transport Proteins (0) ; Dopamine Uptake Inhibitors (0) ; Radiopharmaceuticals (0) ; Tropanes (0) ; Methylphenidate (113-45-1) ; 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane (155797-99-2)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

3/13/1999
1/8/2008
Higher Relevance Score (16)
Lower Relevance Score (11)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index